1. Home
  2. LYB vs EXEL Comparison

LYB vs EXEL Comparison

Compare LYB & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LyondellBasell Industries NV (Netherlands)

LYB

LyondellBasell Industries NV (Netherlands)

N/A

Current Price

$64.24

Market Cap

17.2B

Sector

Industrials

ML Signal

N/A

Logo Exelixis Inc.

EXEL

Exelixis Inc.

N/A

Current Price

$69.12

Market Cap

17.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LYB
EXEL
Founded
1955
1994
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
17.8B
IPO Year
2010
2000

Fundamental Metrics

Financial Performance
Metric
LYB
EXEL
Price
$64.24
$69.12
Analyst Decision
Hold
Buy
Analyst Count
20
17
Target Price
★ $72.28
$61.57
AVG Volume (30 Days)
★ 3.5M
2.5M
Earning Date
10-30-2026
10-29-2026
Dividend Yield
★ 4.32%
N/A
EPS Growth
N/A
★ 57.95
EPS
★ 4.42
2.46
Revenue
★ $30,153,000,000.00
$452,477,000.00
Revenue This Year
$8.76
$10.14
Revenue Next Year
N/A
$12.56
P/E Ratio
★ $14.42
$28.46
Revenue Growth
N/A
★ N/A
52 Week Low
$42.01
$39.71
52 Week High
$83.94
$73.69

Technical Indicators

Market Signals
Indicator
LYB
EXEL
Relative Strength Index (RSI) 53.44 59.84
Support Level $57.19 $55.28
Resistance Level $64.98 $73.69
Average True Range (ATR) 2.35 2.50
MACD -0.29 -0.21
Stochastic Oscillator 60.28 53.04

Price Performance

Historical Comparison
LYB
EXEL

About LYB LyondellBasell Industries NV (Netherlands)

LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Share on Social Networks: